Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery

Documenta Ophthalmologica

Volumn 107, Issue 2, 2003, Pages 87-92

  Demir, Tamer ^a   Turgut, Burak ^b   Celiker, Ulku ^b   Ozercan, Ibrahaim ^b   Ulas, Fatih ^b   Akyol, Nuray ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Amniotic membrane; Octreotide; Trabeculectomy; Wound healing

Indexed keywords

OCTREOTIDE; PREDNISOLONE SODIUM PHOSPHATE;

AMNION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; FIBROBLAST; GLAUCOMA SURGERY; HISTOPATHOLOGY; MACROPHAGE; MALE; MICROSCOPE; NONHUMAN; OPEN ANGLE GLAUCOMA; POSTOPERATIVE PERIOD; RABBIT; SCLERA; TRABECULECTOMY; WOUND HEALING;

AMNION; ANIMALS; CELL COUNT; EYE; FIBROBLASTS; GLAUCOMA; MACROPHAGES; OCTREOTIDE; POSTOPERATIVE PERIOD; RABBITS; TRABECULECTOMY; WOUND HEALING;

EID: 0242549772     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026257227194     Document Type: Article

References (52)

1. Fellman RL. Trabeculectomy. In: Yanoff M, Duker J S (eds.) Ophthalmology. Barcelona: Mosby, 1999; 1-10.
2. Reder JE, Parrish RK. Update of adjunctive antimetabolites in glaucoma surgery. Ophthalmol Clin North Am 1991; 4: 861-88.
3. Hitchings RA, Grierson I. Clinicopathologic correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983; 103: 84-8.
4. Jampel HD, McGuigan LJB, Dunkelberger GR. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol 1988; 106: 89-94.
5. Khaw PT, Occleston NL, Schultz G. Activation and suppression of fibroblast function. Eye 1994; 8: 188-95.
6. Palmberg P. Combined cataract and glaucoma surgery with mitomycin. Ophthalmol Clin North Am 1995; 8: 365-81.
7. Thomas DW, O'Neill ID, Harding KG. Cutaneous wound healing: A current perspective. J Oral Maxillofac Surg 1995; 53: 442-7.
8. Cool DE, Andreassen PR, Tonks NK, Krebs EG, Fischer EH, Morgolis RL. Cytokinetic failure and asynchronous nuclear division in BHK cells overexpressing a truncated protein-tyrosine-phosphates. Proc Natl Acad Sci USA 1992; 89: 5422-26.
9. Danesi R, Agen C, Benelli U, Di Paulo A, Nardini D, et al. Inhibition of experimental angiogenesis by somatostatin analogue octreotide acetate (SMS 201-995). Cancer Res 1997; 3: 265-72.
10. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent ptergyum associated with symbleferon. Br J Ophthalmol 1998; 82: 235-40.
11. Boudreau N, Sympson CJ, Werb Z, Bissel MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-3.
12. Khodadoust AA, Silverstein AM, Kenyon KR, Dowling JE. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am J Ophthalmol 1968; 65: 339-48.
13. Sato H, Shimazaki J, Shinozaki N, Tsubota K. Role of growth factors for ocular surface reconstruction after amniotic membrane transplantation. Invest Ophthalmol Vis Sci 1998; 39: 428.
14. Kim JS, Park SW, Kim JH, Lee SI, Yang HN, Kim JC. Temporary amniotic membrane graft promotes healing and inhibits protease activity in corneal wound induced by alkali burn in rabbits. Invest Ophthalmol Vis Sci 1998; 39: 90-4.
15. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999; 83: 399-402.
16. Tseng SCG, Li D-Q, Ma X. Down-regulation of TGF-β 1, β 2, β 3, and TGG-β receptor II expression in human corneal fibroblasts by amniotic membrane. Invest Ophthalmol Vis Sci 1998; 39: S428.
17. Rennekampff HO, Dohrman P, Fory R, Faundrich F. Evaluation of amniotic membrane as adhesion prophylaxis in a novel surgical gastroschisis model. Invest Surg 1994; 7: 187-93.
18. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surg Las 1998; 29: 428-31.
19. Bryant SM, Fukasawa M, Orita H, Rodgers KE, DiZerega GS. Mediation of post-surgical wound healing by macrophages. Prog Clin Biol Res 1988; 266: 273-90.
20. Johnston RB. Immunology: Monocytes and macrophages. New Engl J Med 1988; 318: 747-52.
21. Leibovich SJ, Wiseman DM. Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 1988; 266: 131-45.
22. Settner A, Morin JD. Healing of trabeculectomies in rabbits. Can J Ophthalmol 1979; 14: 121-5.
23. Pfeiffer RL, Lipper S, Merritt JC. Myofibroblasts in the healing of filtering wounds in rabbit, dog, and cat. Glaucoma 1981; 3: 277-80.
24. Doxey DL, Ng MC, Dill RE. Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995; 57: 1111-23.
25. Levine JH, Moses HL, Gold LI. Spatial and temporal patterns on immunoreactive transforming growth factor β1, β2, and β3 during excisional wound repair. Am J Pathol 1993; 143: 368-80.
26. Mentlein R, Eichler O, Forstreuter F, Held-Feint J. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells. Int J Cancer 2001; 92: 545-50.
27. Cascinu S, Del Ferro E, Ligi M, Staccioli MP, Giordani P, Catalano V, Agostinelli R, Muretto P, Catalano G. Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients. Cancer Invest 2001; 19: 8-12.
28. Amann J, Kaven C, Spraul CW, Lang GK, Lang GE. Effect of octreotide combined with growth factors on proliferation of RPE cells in vitro. Ophthalmologe 2000; 97: 734-41.
29. Soran S, Cete M, Col C. The effect of short-term octreotide administration on the histology structure of stomach, duedenum, jejenum, colon, liver and gall bladder in an experimental pancreatitis model. Tohoku J Exp Med 1998; 185: 101-6.
30. Parmar H, Bogden A, Mollard M, De Rouge B, Phillips RH, Lightman SL. Somatostatin and somatostatin analogues in oncology. Cancer Treat Rev 1989; 16: 95-115.
31. Pejnovic N, Lilic D, Zunic G. Aberrant levels of cytokines within the healing wound after burn injury. Arch Surg 1995; 130: 999-1006.
32. Sullivan KM, Lorenz HP, Meuli M. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 1995; 30: 198-203.
33. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med 1994; 331: 1286-92.
34. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 1992; 339: 213-4.
35. Knorr M, Volker M, Denk PO, Wunderlich K, Thiel HJ. Proliferative response of cultured human Tenon's capsule fibroblasts to platelet-derived growth factor isoforms. Graefes Arch Clin Exp Ophthalmol 1997; 235: 667-71.
36. Saika S, Yamanaka O, Baba Y, Kawashima Y, Shirai K, Miyamoto T, Okada Y, Ohnishi Y, Ooshima A. Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol 2001; 239: 234-41.
37. Denk PO, Roth-Eichhorn S, Gressner AM, Knorr M. Effect of cytokines on regulation of the production of transforming growth factor beta-1 cultured human Tenon's capsule fibroblasts. Eur J Ophthalmol 2000; 10: 110-5
38. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta 2 antibody: A new glaucoma antiscarring agent. Invest Ophthalmol Vis Sci 1999; 40: 2225-34.
39. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994; 59: 723-7.
40. Akyol N, Demir T, Kükner A, Çolakoglu N. Effects of systemic octreotide, local mytomycine-c and local corticosteroids on wound healing reaction after glaucoma surgery. VI. Congress of European Glaucoma Society. Final Programme and Abstracts. 2000; June 25-29. London, 129.
41. Gunal AI, Duman S, Sen S, Unsal A, Terzioglu E, Akcicek F, Basci A. By reducing TGF-β1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol 2001; 14: 184-9.
42. Arias-Diaz J, Vara E, Torres-Melero J, Garcia C, Hernandez J, Balibrea JL. Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: Effects of pentoxifylline and somatostatin. Eur J Surg 1997; 163: 619-25.
43. United States Pharmacopoeia XXIII 1995;1945-6.
44. Baran K, Nuray A, Mehmet G, Hikmet K. Effect of topical and subcutaneous octreotide acetate on corneal stromal haze after photorefractive keratectomy in rabbits. XVIIth Congress of the European Society of Cataract and Refractive Surgeons Vienna, 1999; 98.
45. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116: 431-41.
46. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol 1999; 83: 748-52.
47. Adinofli M, Akle CA, McColl I, et al. Expression of HLA antigens, β2-microglobulin and enzymes by human amniotic membrane. Nature 1982; 295: 325-7.
48. Talmi YP, Sigler L, Inge E. Antibacterial properties of human amniotic membranes. Placenta 1991; 12: 285-8.
49. Tseng SCG, Li D-Q, Ma X. Suppression of TGF-β 1, β 2, β 3, and TGG-β receptor II expression and myofibroblast differentiation in human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 1999; 179: 325-35.
50. Franch A, Rama P, Lambiase A. Human amniotic membrane transplantation. Invest Ophthalmol Vis Sci 1998; 39: 90-6.
51. Barton K, Budenz DL, Khaw PT, Tseng SC. Amniotic membrane transplantation in glaucoma surgery. Invest Ophthalmol Vis Sci 1997; 38: 473-7.
52. Barton K, Budenz DL, Khaw PT, Tseng SC. Glaucoma filtration surgery using amniotic membrane transplantation. Invest Ophthalmol Vis Sci 2001; 42: 1762-8.